Related Experiment Videos
Structure -activity relationships of PDE5 inhibitors
D Eros1, Cs Szántai-Kis, R Kiss
1Vichem Chemie Ltd., Herman Ottó u. 15., Budapest, 1022, Hungary.
Current Medicinal Chemistry
|August 5, 2008
Summary
This study analyzes 438 compounds targeting cyclic guanosine monophosphate-specific phosphodiesterase type 5 (PDE5) to understand structure-activity relationships. The findings aid in developing new PDE5 inhibitors for conditions like erectile dysfunction and pulmonary hypertension.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Biochemistry
Background:
- Cyclic guanosine monophosphate (cGMP) regulates smooth muscle tone and cellular responses.
- cGMP-Phosphodiesterase type 5 (PDE5) hydrolyzes cGMP, leading to smooth muscle contraction.
- PDE5 is a therapeutic target for erectile dysfunction and pulmonary hypertension.
Purpose of the Study:
- To compile and analyze existing cGMP-PDE5 inhibitory data.
- To establish structure-activity relationships (SAR) for PDE5 inhibitors.
- To develop a quantitative structure-activity relationship (QSAR) model for PDE5 inhibitors.
Main Methods:
- Literature search for chemical structures and IC50 values of 438 compounds.
- Tabulation of inhibitors based on core structures.
- Development of a general QSAR model using collected data.
Main Results:
- A comprehensive dataset of 438 cGMP-PDE5 inhibitors was assembled.
- The study discusses PDE5 physiology, regulation, and inhibition.
- A QSAR model was constructed to predict inhibitory activity.
Conclusions:
- Understanding SAR is crucial for designing effective PDE5 inhibitors.
- The developed QSAR model can guide future drug discovery efforts.
- This work provides a valuable resource for researchers in the field of PDE5 inhibition.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...